The FDA has allowed an Investigational New Drug (IND) application to initiate a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Read more...
The FDA has allowed an Investigational New Drug (IND) application to initiate a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Read more...